Skip to contentSkip to Braille Studio

Library / Laws / 115th Congress / House Bills / H.R. 2025

H.R. 2025

To amend section 505(c)(3)(E) of the Federal Food, Drug, and Cosmetic Act to prevent certain applications from being considered ineligible for approval under section 505(c) of such Act on the basis that the proposed labeling includes information describing abuse-deterrent properties that otherwise would be blocked by exclusivity under clause (iii) or (iv) of section 503(c)(3)(E) of such Act, and for other purposes.

Print stageDateSize⠃
Introduced in House2017-04-062.8K⠃⠗⠋